Spaventa Andrew
- SEC CIK
- 0001859701
No open-market purchases or sales filed in the past year.
Current role at each company
- OMIC Singular Genomics Systems, Inc.Chief Executive Officeras of Feb 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Spaventa Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 (view filing) | Feb 14 | Same day | Spaventa AndrewChief Executive Officer | SSale | −800 | $19.89 | −$15.9K | −35.8%1.43K after | |
| Dec 17, 2024 (view filing) | Dec 16 | 1 day | Spaventa AndrewChief Executive Officer | SSale | −180 | $20.16 | −$3.63K | −22.2%631 after | |
| Nov 13, 2024 (view filing) | Nov 12 | 1 day | Spaventa AndrewChief Executive Officer | SSale | −695 | $22.55 | −$15.7K | −31.1%1.54K after | |
| Sep 17, 2024 (view filing) | Sep 15 | 2 days | Spaventa AndrewChief Executive Officer | SSale | −175 | $12.38 | −$2.17K | −21.6%637 after | |
| Nov 20, 2023 (view filing)4:31 PM ET | Nov 16-17 | 4 days | Spaventa AndrewChief Executive Officer | PPurchase | +118.5K | $0.4188 | +$49.6K | +3.0%4.06M after | 2 lots |